logo-loader

Anima in talks with 'over ten companies' to use its translation control therapeutics platform.

Published: 11:42 15 Feb 2019 EST

Anima Biotech CEO Yochi Slonim sat down with Proactive Investors at the BIO CEO & Investor Conference in New York. 

Israel based Anima Biotech is pioneering translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against "hard and undruggable" targets.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

39 minutes ago